Heat shock proteins as endogenous adjuvants in sterile and septic inflammation

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 2777-2782

  Quintana, Francisco J ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; LIGAND; TOLL LIKE RECEPTOR;

AUTOIMMUNITY; BACTERIUM; CANCER THERAPY; CONTAMINATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; PATHOGENICITY; PRIORITY JOURNAL; SEPTIC INFLAMMATION; SHORT SURVEY;

EID: 23844482773     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.2777     Document Type: Short Survey

References (104)

1. Ritossa, F. 1996. Discovery of the heat shock response. Cell Stress Chaperones 1: 97-98.
2. Hartl, F. U., and M. Hayer-Hartl. 2002. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295: 1852-1858.
3. Elias, D., D, Markovits, T. Reshef, R. van der Zee, and I. R. Cohen. 1990. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 87: 1576-1580.
4. Abulafia-Lapid, R., D. Elias, I. Raz, Y. Keren-Zur, H. Atlan, and I. R. Cohen. 1999. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun. 12: 121-129.
5. Abulafia-Lapid, R., D. Gillis, O. Yosef, H. Atlan, and I. R. Cohen. 2003. T cells and autoantibodies co human HSP70 in type 1 diabetes in children. J. Autoimmun. 20: 313-321.
6. Gaston, J. S., P. F. Life, L. C. Bailey, and P. A. Bacon. 1989. In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J. Immunol. 143: 2494-2500.
7. van Eden, W., J. E. Thole, R. van der Zee, A. Noordzij, J. D. van Embden, E. J. Hensen, and I. R. Cohen. 1988. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331: 171-173.
8. Blass, S., A. Union, J. Raymackers, F. Schumann, U. Ungethum, S. Muller-Steinbach, F. De Keyser, J. M. Engel, and G. R. Burmester. 2001. The stress procein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum. 44: 761-771.
9. Corrigall, V. M., M. D. Bodman-Smith, M. S. Fife, B. Canas, L. K. Myers, P. Wooley, C. Soh, N. A. Staines, D. J. Pappin, S. E. Berlo, et al. 2001. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J. Immunol. 166: 1492-1498.
10. Lehner, T. 1997. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease. Int. Rev. Immunol. 14: 21-32.
11. Dhillon, V., D. Latchman, and D. Isenberg. 1991. Heat shock proteins and systemic lupus erythematosus. Lupus 1: 3-8.
12. Quintana, F. J., P. Carmi, F. Mor, and I. R. Cohen. 2002. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J. Immunol. 169: 3422-3428.
13. Quintana, F. J., P. Carmi, F. Mor, and I. R. Cohen. 2003. DNA fragments of human HSP60 vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J. Immunol. 171: 3533-3541.
14. Quintana, F. J., P. Carmi, F. Mor, and I. R. Cohen. 2004. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum. 50: 3712-3720.
15. Prakken, A. B., W. van Eden, G. T. Rijkers, W. Kuis, E. A. Toebes, E. R. de Graeff-Meeder, R. van der Zee, and B. J. Zegers. 1996. Auto reactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 39: 1826-1832.
16. Tanaka, S., Y. Kimura, A. Mitani, G. Yamamoto, H. Nishimura, R. Spallek, M. Singh, T. Noguchi, and Y. Yoshikai. 1999. Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J. Immunol. 163:5560-5565.
17. Ulmansky, R., C. J. Cohen, F. Szafer, E. Moallem, Z. G. Fridlender, Y. Kashi, and Y. Naparstek. 2002. Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion. J. Immunol. 168: 6463-6469.
18. Elias, D., T. Reshef, O. S. Bitk, R. van der Zee, M. D. Walker, and I. R. Cohen. 1991. Vaccination against autoimmune mouse diabetes with a T cell epitope of ehe human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091.
19. Quintana, F. J., P. Carmi, and I. R. Cohen. 2002. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J. Immunol. 169: 6030-6035.
20. Raz, I., D. Elias, A. Avron, M. Tamir, M. Metzget, and I. R. Cohen. 2001. β Cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358: 1749-1753.
21. + CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule. Vaccine 17: 373-383.
22. Blachere, N. E., Z. Li, R. Y. Chandawarkar, R. Suto, N. S. Jaikaria, S. Basu, H. Udono, and P. K. Srivastava. 1997. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186: 1315-1322.
23. Srivastava, P. 2002. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2: 185-194.
24. Beg, A. A. 2002. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23: 509-512.
25. Zanin-Zhorov, A., G. Tal, S. Shivtiel, M. Cohen, T. Lapidot, G. Nussbaum, R. Margalit, I. R. Cohen, and O. Lider. 2005. Heat shock protein 60 activates cytokine-associated negative regulator SOCS3 in T cells: effects on signaling, chemotaxis, and inflammation. J. Immunol. 175: 276-285.
26. Zanin-Zhorov, A., R. Bruck, G. Tal, S. Oren, H. Aeed, R. Hershkoviz, I. R. Cohen, and O. Lider. 2005. Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J. Immunol. 174:3227-3236.
27. Zanin-Zhorov, A., G. Nussbaum, S. Franicza, I. R. Cohen, and O. Lider. 2003. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 17: 1567-1569.
28. Wallin, R. P., A. Lundqvist, S. H. More, A. von Bonin, R. Kiessling, and H. G. Ljunggren. 2002. Heat-shock proteins as activators of the innate Immune system. Trends Immunol. 23: 130-135.
29. Rico, A. I., S. O. Angel, C. Alonso, and J. M. Requena. 1999. Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol. Immunol. 36: 1131-1139.
30. Rico, A. I., N. Girones, M. Fresno, C. Alonso, and J. M. Requena. 2002. The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones 7: 339-346.
31. Gao, B., and M. F. Tsan. 2003. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages. J. Biol. Chem. 278: 22523-22529.
32. Gao, B., and M. F. Tsan. 2003. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor α release by murine macrophages. J. Biol. Chem. 278: 174-179.
33. Gao, B., and M. F. Tsan. 2004. Induction of cytokines by heat shock proteins and endotoxin in murine macrophages. Biochem. Biophys. Res. Commun. 317: 1149-1154.
34. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
35. Chen, W., U. Syldath, K. Bellmann, V. Burkart, and H. Kolb. 1999. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J. Immunol. 162:3212-3219.
36. Basu, S., R. J. Binder, R. Suto, K. M. Anderson, and P. K. Srivastava. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12: 1539-1546.
37. Vabulas, R. M., P. Ahmad-Nejad, S. Chose, C. J. Kirschning, R. D. Issels, and H. Wagner. 2002. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277: 15107-15112.
38. Darveau, R. P., T. T. Pham, K. Lemley, R. A. Reife, B. W. Bainbridge, S. R. Coats, W. N. Howald, S. S. Way, and A. M. Hajjar. 2004. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect. Immun. 72: 5041-5051.
39. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
40. Quteshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189: 615-625.
41. Panjwani, N. N., L. Popova, and P. K. Srivastava. 2002. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J. Immunol. 168: 2997-3003.
42. Korbelik, M., J. Sun, and I. Cecic. 2005. Photodynamic therapy-induced cell surface expression and release of heat shock proteins; relevance for tumor response. Cancer Res. 65: 1018-1026.
43. Osterloh, A., F. Meier-Stiegen, A. Veit, B. Fleischer, A. Von Bonin, and M. Breloer. 2004. LPS-free heat shock protein 60 activates T cells. J. Biol. Chem. 279: 47906-47911.
44. Gastpar, R., C. Gross, L. Rossbacher, J. Ellwart, J. Riegger, and G. Multhoff. 2004. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J. Immunol. 172: 972-980.
45. Reits, E., J. Neijssen, C. Herberts, W. Benckhuijsen, L. Janssen, J. W. Drijfhout, and J. Neefjes. 2004. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20: 495-506.
46. Reits, E., A. Griekspoor, J. Neijssen, T. Groothuis, K. Jalink, P. van Veelen, H. Janssen, J. Calafat, J. W. Drijfhout, and J. Neefjes. 2003. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18: 97-108.
47. Basu, S., and P. K. Srivastava. 1999. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J. Exp. Med. 189:797-802.
48. Rivoltini, L., C. Castelli, M. Cartabba, V. Mazzaferro, L. Pilla, V. Huber, J. Coppa, G. Gallino, C. Scheibenbogen, P. Squarcina, et al. 2003. Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells. J. Immunol. 171: 3467-3474.
49. Cwiklinska, H., M. P. Mycko, O. Luvsannorov, B. Walkowiak, C. F. Brosnan, C. S. Raine, and K. W. Selmaj. 2003. Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains. Int. Immunol. 15: 241-249.
50. Galazka, G., A. Walczak, T. Betkowicz, and K. Selmaj. 2001. Effect of Hsp70-peptide complexes generated in vivo on modulation EAE. Adv. Exp. Med. Biol 495: 227-230.
51. Mycko, M. P., H. Cwiklinska, J. Szymanski, B. Szymanska, G. Kudla, L. Kilianek, A. Odyniec, C. F. Brosnan, and K. W. Selmaj. 2004. Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II. J. Immunol. 172: 202-213.
52. Martin, C. A., S. E. Carsons, R. Kowalewski, D. Bernstein, M. Valentino, and F. Santiago-Schwarz. 2003. Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: possible mechanisms of hsp/DC-mediated cross-priming. J. Immunol. 171: 5736-5742.
53. Chandawarkar, R. Y., M, S. Wagh, and P. K. Srivastava. 1999. The dual nature of specific immunological activity of tumor-derived gp96 preparations. J. Exp. Med. 189: 1437-1442.
54. Chandawarkar, R. Y., M. S. Wagh, J. T. Kovalchin, and P. Srivastava. 2004. Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis. Int. Immunol. 16: 615-624.
55. SenGupta, D., P. J. Norris, T. J. Suscovich, M. Hassan-Zahraee, H. F. Moffett, A. Trocha, R. Draenert, P. J. Goulder, R. J. Binder, D. L. Levey, et al. 2004. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. J. Immunol. 173: 1987-1993.
56. Chu, N. R., H. B. Wu, T. Wu, L. J. Boux, M. I. Siegel, and L. A. Mizzen. 2000. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guerin (BCG) hsp65 and HPV16 E7. Clin. Exp. Immunol. 121: 216-225.
57. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20: 709-760.
58. Bandholtz, L., Y. Guo, C. Palmberg, K. Mattsson, B. Ohlsson, A. High, J. Shabanowitz, D. F. Hunt, H. Jornvall, H. Wigzell, B. Agerberth, and G. H. Gudmundsson. 2003. Hsp90 binds CpG oligonucleotides directly: implications for hsp90 as a missing link in CpG signaling and recognition. Cell. Mol. Life Sci. 60:422-429.
59. Zhu, F. G., and D. S. Pisetsky. 2001. Role of the heat shock protein 90 in immune response stimulation by bacterial DNA and synthetic oligonucleotides. Infect. Immun. 69: 5546-5552.
60. Triantafilou, K., M. Triantafilou, and R. L. Dedrick. 2001. ACD14-independent LPS receptor cluster. Nat. Immunol. 2: 338-345.
61. Reed, R. C., B. Berwin, J. P. Baker, and C. V. Nicchitta. 2003. GRP94/gp96 elicits ERK activation in murine macrophages: a role for endotoxin contamination in NF-κB activation and nitric oxide production. J. Biol. Chem. 278: 31853-31860.
62. Byrd, C. A., W. Bornmann, H. Erdjument-Bromage, P. Tempst, N. Pavletich, N. Rosen, C. F. Nathan, and A. Ding. 1999. Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 96: 5645-5650.
63. Triantafilou, M., and K. Triantafilou. 2004. Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem. Soc. Trans. 32: 636-639.
64. Campisi, J., T. H. Leem, and M. Fleshner. 2003. Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system. Cell Stress Chaperones 8: 272-286.
65. Cohen, I. R., F. J. Quintana, and A. Mimran. 2004. Tregs in T cell vaccination: exploring the regulation of regulation. J. Clin. Invest. 114: 1227-1232.
66. Dybdahl, B., A. Wahba, E. Lien, T. H. Flo, A. Waage, N. Qureshi, O. F. Sellevold, T. Espevik, and A. Sundan. 2002. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through Toll-like receptor-4. Circulation 105: 685-690.
67. Schett, G., B. Metzler, R. Kleindienst, A. Amberger, H. Recheis, Q. Xu, and G. Wick. 1999. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc. Res. 42: 685-695.
68. Xu, Q., G. Schett, H. Perschinka, M. Mayr, G. Egger, F. Oberhollenzer, J. Willeit, S. Kiechl, and G. Wick. 2000. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102: 14-20.
69. Lancaster, G. I., and M. A. Febbraio. 2005. Exosome-dependent trafficking of HSP70: A novel secretory pathway for cellular stress proteins. J. Biol. Chem. 280: 23349-23355.
70. Liu, B., J. Dai, H. Zheng, D. Stoilova, S. Sun, and Z. Li. 2003. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc. Natl. Acad. Sci. USA 100: 15824-15829.
71. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
72. Millar, D. G., K. M. Garza, B. Odermatt, A. R. Elford, N. Ono, Z. Li, and P. S. Ohashi. 2003. Hsp70 promotes antigen-presenting cell function and converts T cell tolerance to autoimmunity in vivo. Nat. Med. 9: 1469-1476.
73. Kumaraguru, U., C. D. Pack, and B. T. Rouse. 2003. Toll-Like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins. J. Leukocyte Biol. 73:574-583.
74. Saito, K., H. Katsuragi, M. Mikami, C. Kato, M. Miyamaru, and K. Nagaso. 1997. Increase of heat-shock protein and induction of γ/δ T cells in peritoneal exudate of mice after injection of live Fusobacterium nucleatum. Immunology 90: 229-235.
75. Teshima, S., K. Rokutan, M. Takahashi, T. Nikawa, and K. Kishi. 1996. Induction of heat shock proteins and their possible roles in macrophages during activation by macrophage colony-stimulating factor. Biochem. J. 315(Pt 2): 497-504.
76. Vabulas, R. M., P. Ahmad-Nejad, C. da Costa, T. Miethke, C. J. Kirschning, H. Hacker, and H. Wagner. 2001. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276: 31332-31339.
77. Lehner, M, D., S. Morath, K. S. Michelsen, R. R. Schumann, and T. Hartung. 2001. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166: 5161-5167.
78. Sato, S., F. Nomura, T. Kawai, O. Takeuchi, P. F. Muhlradt, K. Takeda, and S. Akira. 2000. Synergy and cross-tolerance between Toll-like receptor (TLR)2- and TLR4-mediated signaling pathways. J. Immunol. 165: 7096-7101.
79. Hajishengallis, G., M. Martin, R. E. Schifferle, and R. J. Genco. 2002. Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors. Infect. Immun. 70: 6658-6664.
80. Martin, M., J. Katz, S. N. Vogel, and S. M. Michalek. 2001. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J. Immunol. 167: 5278-5285.
81. Dobrovolskaia, M. A., A. E. Medvedev, K. E. Thomas, N. Cuesta, V. Toshchakov, T. Ren, M. J. Cody, S. M. Michalek, N. R. Rice, and S. N. Vogel. 2003. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-κB signaling pathway components. J. Immunol. 170: 508-519.
82. Deiters, U., M. Gumenscheimer, C. Galanos, and P. F. Muhlradt. 2003. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor α but in only partial protection from lethal LPS doses. Infect. Immun. 71: 4456-4462.
83. Schuchmann, M., F. Hermann, J. Herkel, R. van der Zee, P. R. Galle, and A. W. Lohse. 2004. HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells. Immunol. Lett. 93: 199-204.
84. Kilmartin, B., and D. J. Reen. 2004. HSP60 induces self-tolerance to repeated HSP60 stimulation and cross-tolerance to other pro-inflammatory stimuli. Eur. J. Immunol. 34: 2041-2051.
85. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.
86. Ebert, R. H. 1965. The Inflammatory Process. Academic Press, New York.
87. Cohen, I. R. 2000. Tending Adam's Garden: Evolving the Cognitive Immune Self. Academic Press, London.
88. Cohen, I. R. 2000. Discrimination and dialogue in the immune system. Semin. Immunol. 12:215-219.
89. Schwartz, M., and I. R. Cohen. 2000. Autoimmunity can benefit self-maintenance. Immunol. Today 21: 265-268.
90. Quintana, F. J., P. H. Hagedorn, G. Elizur, Y. Merbl, E. Domany, and I. R. Cohen. 2004. Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc. Natl. Acad. Sci. USA 101(Suppl. 2): 14615-14621.
91. Ueki, K., K. Tabeta, H. Yoshie, and K. Yamazaki. 2002. Self-heat shock protein 60 induces tumour necrosis factor α in monocyte-derived macrophage: possible role in chronic inflammatory periodontal disease. Clin. Exp. Immunol. 127: 72-77.
92. Ohashi, K., V. Burkart, S. Flohe, and H. Kolb. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164:558-561.
93. Bulut, Y., E. Faure, L. Thomas, H. Karahashi, K. S. Michelsen, O. Equils, S. G. Morrison, R. P. Morrison, and M. Arditi. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168: 1435-1440.
94. Basu, S., R. J. Binder, T. Ramalingam, and P. K. Srivastava. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313.
95. Asea, A., M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, and S. K. Calderwood. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR)2 and TLR4. J. Biol. Chem. 277: 15028-15034.
96. Delneste, Y., G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamuta, J. Bonnefoy, and P. Jearmin. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362.
97. Wang, Y., C. G. Kelly, J. T. Kamunen, T. Whittall, P. J. Lehner, L. Duncan, P. MacAry, J. S. Younson, M. Singh, W. Oehlmann, et al. 2001. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 15: 971-983.
98. Lazarevic, V., A. J. Myers, C. A. Scanga, and J. L. Flynn. 2003. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19: 823-835.
99. Becker, T., F. U. Hartl, and F. Wieland. 2002. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158: 1277-1285.
100. Asea, A., S. K. Kraeft, E. A. Kurt-Jones, M. A. Stevenson, L. B. Chen, R. W. Finberg, G. C. Koo, and S. K. Calderwood. 2000. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6: 435-442.
101. Kol, A., A. H. Lichtman, R. W. Finberg, P. Libby, and E. A. Kurt-Jones. 2000. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 164: 13-17.
102. Gross, C., D. Hansch, R. Gastpar, and G. Multhoff. 2003. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol. Chem. 384: 267-279.
103. Berwin, B., J. P. Hart, S. Rice, C. Gass, S. V. Pizzo, S. R. Post, and C. V. Nicchitta. 2003. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 22: 6127-6136.
104. Vabulas, R. M., S. Braedel, N. Hilf, H. Singh-Jasuja, S. Herter, P. Ahmad-Nejad, C. J. Kirschning, C. Da Costa, H. G. Rammensee, H. Wagner, and H. Schild. 2002. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277: 20847-20853.